Delivery Order SPE2DB20D6035-SPE2DB25FLYGV
- Not listed
- This is a $3,162.71 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a specialty pharmaceutical product, with a period of performance through February 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of FERAHEME, a specialty pharmaceutical product. The delivery order, valued at $5,988.60, is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,183.21, is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $3,385.70 contract is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product, with a period of performance through April 18, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,850.94, is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a medical supply product. This is a Firm Fixed Price Delivery Order contract with a completion date of November 14, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a larger...
- This is a $3,470.02 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568318214 - FERAHEME 510 MG/17 ML VIAL 17ML. The contract has an ultimate completion date of May 22, 2025 and is not set aside. AmerisourceBergen Drug Corp is a critical supplier of pharmaceutical products and medical supplies to various federal agencies, particularly the military healthcare system,...
- This federal contract award, valued at $2,358.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FERAHEME 510 MG/17 ML VIAL 17ML, a medical product, with a completion date of February 18, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. AmerisourceBergen holds a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $14,921.25, is for the provision of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product, with a period of performance through March 29, 2024. This delivery order is placed against an indefinite delivery contract (IDC) awarded to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $3,388.30, is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The delivery order is a firm fixed price contract with a completion date of February 2, 2024. No set-aside designation was used for this...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,177.57 firm fixed-price delivery order is for the supply of FERAHEME 510 MG/17 ML VIAL 17ML, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB25FLYGVDelivery Order
The Defense Logistics Agency awarded a $5,257.45 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of FERAHEME 510 mg/17 ml vials. The contract utilizes a firm fixed price structure with a completion date of September 8, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location, serving as a critical pharmaceutical distributor for federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability to meet Defense Logistics Agency requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 9/5/25 |